Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Do Genetic Contributors to Warfarin Responsiveness or Common Thrombophilias Influence the Risk of Major Bleeding in Patients on Extended Duration Vitamin K Antagonist (VKA) for Venous Thromboembolic Disease?

Philip S Wells, MD, Michael J. Kovacs, MD FRCPC, David Anderson, MD, Susan R. Kahn, MD, Clive Kearon, MB, Sam Schulman, MD PhD FRCPC, David M. Keeling, MD, Scott Kaatz, DO, MSc, Susan Solymoss, MD, Daniel J Corsi, PhD, Marc Rodger, MD MSc, FRCPC

Blood (2016) 128 (22): 272.

https://doi.org/10.1182/blood.V128.22.272.272

Published: 2016

Journal Articles

Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism

Blood (2016) 128 (22): 139.

https://doi.org/10.1182/blood.V128.22.139.139

Published: 2016

Journal Articles

Post-Thrombotic Syndrome and Functional Disability in Patients with Upper Extremity Deep Vein Thrombosis: A Prospective Cohort Study

Alejandro Lazo-Langner, MD MSc, FRCPC, Susan R Kahn, MD MSc, Philip S Wells, MD, David Anderson, MD, Marc Rodger, MD MSc, Marc Carrier, MD MSc, FRCPC, Annmarie A. Bosco, MBBS, BSc (MD, Judy Kovacs, RN, Roweena Corpuz, RN, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 417.

https://doi.org/10.1182/blood.V128.22.417.417

Published: 2016

Journal Articles

Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism

Matthew R. Kovacs, Alejandro Lazo-Langner, MD MSc, FRCPC, Martha L Louzada, MD, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 5017.

https://doi.org/10.1182/blood.V128.22.5017.5017

Published: 2016

Journal Articles

A Pilot Study in Cancer Patients with Central Venous Catheter Associated Deep Vein Thrombosis in Upper Extremity Treated with Rivaroxaban (Catheter 2)

Gwynivere A Davies, MD FRCPC, Alejandro Lazo-Langner, MD MSc, FRCPC, Esteban Gandara, MD MSc, FRCPC, Vicky Tagalakis, MD MSc, Martha L Louzada, MD, Roweena Corpuz, RN, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 878.

https://doi.org/10.1182/blood.V128.22.878.878

Published: 2016

Journal Articles

Safety of Weight-Adjusted Dosing of LMWH in Clinically Obese Cancer Patients with Venous Thromboembolism

Gillian Mount, MD MSc, Michael J. Kovacs, MD FRCPC, Alejandro Lazo-Langner, MD MSc, FRCPC, Lenicio Siqueira, BSc, Martha L Louzada, MD

Blood (2016) 128 (22): 882.

https://doi.org/10.1182/blood.V128.22.882.882

Published: 2016

Journal Articles

Long Term Monitoring of Patients with Positive Lupus Anticoagulant and Antiphospholipid Antibodies. Are All Cases Persistently Positive?

Matthew R. Kovacs, Alejandro Lazo-Langner, MD MSc, FRCPC, Martha L Louzada, MD, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 1452.

https://doi.org/10.1182/blood.V128.22.1452.1452

Published: 2016

Journal Articles

Updates on the Risk of Dalteparin Thromboprophylaxis Failure in Hospitalized Acutely Ill Medical Patients with Cancer (ARTIC STUDY)

Martha L Louzada, BSc, MD MSc, Fatimah Al-Ani, MD MRCP, Michael J. Kovacs, MD FRCPC, Lenicio Siqueira, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2015) 126 (23): 1116.

https://doi.org/10.1182/blood.V126.23.1116.1116

Published: 2015

Journal Articles

A Prospective Cohort Study of Upper Extremity Deep Vein Thrombosis

Alejandro Lazo-Langner, MD MSc, Susan R Kahn, MD MSc, Philip S Wells, MDMSc, David Anderson, MD, Marc Rodger, MD MSc, Marc Carrier, MD MSc, Annmarie A. Bosco, MBBS, BSc (MD, Judy Kovacs, RN, Roweena Corpuz, RN, Michael J. Kovacs, MD FRCPC

Blood (2015) 126 (23): 893.

https://doi.org/10.1182/blood.V126.23.893.893

Published: 2015

Journal Articles

Management of T-Cell Large Granular Lymphocyte Leukemia with Methotrexate or Cyclophosphamide

Matthew R. Kovacs, Cyrus C. Hsia, MDBSc,FRCPC, Alejandro Lazo-Langner, MD MSc, Michael J. Kovacs, MD FRCPC

Blood (2015) 126 (23): 5290.

https://doi.org/10.1182/blood.V126.23.5290.5290

Published: 2015

Journal Articles

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism: A Retrospect of Real Life (EXTEND Study)

Martha L Louzada, BSc, MD MSc, Michael J. Kovacs, MD FRCPC, Fatimah Al-ani, MD, Lenicio Siqueira, Alejandro Lazo-Langner, MD MSc

Blood (2014) 124 (21): 4245.

https://doi.org/10.1182/blood.V124.21.4245.4245

Published: 2014

Journal Articles

Impact of Transition to Generic Imatinib in the Molecular Response Among Patients with Chronic Myeloid Leukemia

Matthew Kang, BHSc, MD FRCPC, Anargyros Xenocostas, MD FRCPC, Alejandro Lazo-Langner, MD MSc, Ian H. Chin-Yee, MD FRCPC, Kang Howson-Jan, MD, Maisam Abouzeenni, BHSc, Michael J. Kovacs, MD FRCPC, Cyrus C. Hsia, BSc, MD FRCPC

Blood (2014) 124 (21): 5527.

https://doi.org/10.1182/blood.V124.21.5527.5527

Published: 2014

Journal Articles

Family History of Venous Thromboembolism (VTE) and the Risk of VTE Recurrence in Patients with a First Unprovoked VTE: A Multicenter Prospective Cohort Study

Karine Gauthier, BSc, Elham Sabri, M.Sc., Susan R. Kahn, MD, MSc, Philip S Wells, David Anderson, Gregoire Le Gal, MD, PhD, Susan Solymoss, MD, Mark A. Crowther, MD, FRCPC, Arnaud Perrier, Richard H. White, MD, Michael J. Kovacs, MD, FRCPC, Marc Carrier, MD, MSc, Marc A. Rodger, MD, FRCPC

Blood (2011) 118 (21): 2299.

https://doi.org/10.1182/blood.V118.21.2299.2299

Published: 2011

Journal Articles

Relationship Between Subtherapeutic Warfarin Anticoagulation and the Development of Post Thrombotic Syndrome After a First Unprovoked Deep Vein Thrombosis: Results From the REVERSE Cohort Study

Rufaro S. Chitsike, MD, Susan R. Kahn, MD, MSc, Michael J. Kovacs, MD, FRCPC, Marisol T. Betancourt, MD, MSc, Philip S Wells, David Anderson, MD, Isabelle Chagnon, MD, Gregoire Le Gal, MD, PhD, Susan Solymoss, MD, Mark A. Crowther, MD, FRCPC, Arnaud Perrier, Richard H. White, MD, Linda Vickars, Tim Ramsay, Marc A. Rodger, MD, FRCPC

Blood (2011) 118 (21): 712.

https://doi.org/10.1182/blood.V118.21.712.712

Published: 2011

Journal Articles

Conservative Peri-Procedural Anticoagulation Management in Patients with Venous Thromboembolic Disease Results in a Low Proportion of Thrombosis and Bleeding

Leslie Skeith, MD, Jay Taylor, MSc, Alejandro Lazo-Langner, MD, MSc, Michael J. Kovacs, MD, FRCPC

Blood (2011) 118 (21): 546.

https://doi.org/10.1182/blood.V118.21.546.546

Published: 2011

Journal Articles

Study of Octaplex Dosing Accuracy: An In Vitro Analysis

Christopher Jordan Patriquin, BHSc, MD, Ian H. Chin-Yee, MD, FRCPC, Michael J. Kovacs, MD, FRCPC, Alejandro Lazo-Langner, MD, MSc, Michael Keeney, ART, FIMLS, FCSMLS(D), Cyrus C. Hsia, BSc, MD, FRCPC

Blood (2011) 118 (21): 4335.

https://doi.org/10.1182/blood.V118.21.4335.4335

Published: 2011

Journal Articles

A Canadian Expanded Access Trial of Oral Nilotinb in Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Robert Delage, MD, MSc, FRCP, A. Robert Turner, MD, FRCPC, Brian Leber, MD, Wanda S. Hasegawa, MD, Denis-Claude Roy, MD, Mary Lynn Savoie, MD, Heather A Leitch, MD, PhD, Isabelle Bence-Bruckler, MD, FRCPC, Donna L. Forrest, MD, Sindu Kanjeekal, MD, Sehdev Sandeep, MD, Pierre Laneuville, MD, Sarit Assouline, MD, Kuljit Grewal, MD, Michael J. Kovacs, MD, FRCPC, Wendy Lam, MD, Annie Woo, M.Sc., Pierre Beauparlant, Ph.D., Jeffrey H. Lipton, MD, PhD

Blood (2011) 118 (21): 4437.

https://doi.org/10.1182/blood.V118.21.4437.4437

Published: 2011

Journal Articles

Prospective Canadian Trial In Newly Diagnosed Multiple Myeloma Patients with t(4;14): Bortezomib-Based Therapy without ASCT

Donna E. Reece, MD, Giovanni Piza Rodriguez, Andrew Belch, MD, David Szwajcer, MD, FRCP(C), Michael J. Kovacs, MD, FRCPC, Chaim Shustik, MD, Nizar J Bahlis, MD, Darrell J White, MD, Mariela Pantoja, Christine Chen, MD, Vishal Kukreti, MD, FRCPC, Peter Anglin, MD, Suzanne Trudel, MD, MSC, FRCPC

Blood (2010) 116 (21): 1968.

https://doi.org/10.1182/blood.V116.21.1968.1968

Published: 2010

Journal Articles

A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial

A. Keith Stewart, Suzanne Trudel, MD, MSC, FRCPC, Nizar J Bahlis, MD, Darrell J White, MD, Waleed Sabry, MSc, MD, Andrew Belch, MD, Tony Reiman, MD, Jean Roy, MD, FRCPC, Chaim Shustik, MD, Michael J. Kovacs, MD, FRCPC, Jonathan Sussman, Ralph M. Meyer, MD, Erica L Harnett, M.Sc., Danila Oana, Judy A Chapman, Lois Shepherd, MD

Blood (2010) 116 (21): 39.

https://doi.org/10.1182/blood.V116.21.39.39

Published: 2010

Journal Articles

Development of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Martha L Louzada, BSc, MD, Alejandro Lazo-Langner, MD, MSC, Vi Dao, MD, Jerry Zhang, MD, Michael J. Kovacs, MD, FRCPC, Marc Carrier, MD, MSc, Marc Rodger, Phil Wells

Blood (2010) 116 (21): 475.

https://doi.org/10.1182/blood.V116.21.475.475

Published: 2010

NARROW

Do Genetic Contributors to Warfarin Responsiveness or Common Thrombophilias Influence the Risk of Major Bleeding in Patients on Extended Duration Vitamin K Antagonist (VKA) for Venous Thromboembolic Disease?

Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism

Post-Thrombotic Syndrome and Functional Disability in Patients with Upper Extremity Deep Vein Thrombosis: A Prospective Cohort Study

Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism

A Pilot Study in Cancer Patients with Central Venous Catheter Associated Deep Vein Thrombosis in Upper Extremity Treated with Rivaroxaban (Catheter 2)

Safety of Weight-Adjusted Dosing of LMWH in Clinically Obese Cancer Patients with Venous Thromboembolism

Long Term Monitoring of Patients with Positive Lupus Anticoagulant and Antiphospholipid Antibodies. Are All Cases Persistently Positive?

Updates on the Risk of Dalteparin Thromboprophylaxis Failure in Hospitalized Acutely Ill Medical Patients with Cancer (ARTIC STUDY)

A Prospective Cohort Study of Upper Extremity Deep Vein Thrombosis

Management of T-Cell Large Granular Lymphocyte Leukemia with Methotrexate or Cyclophosphamide

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism: A Retrospect of Real Life (EXTEND Study)

Impact of Transition to Generic Imatinib in the Molecular Response Among Patients with Chronic Myeloid Leukemia

Family History of Venous Thromboembolism (VTE) and the Risk of VTE Recurrence in Patients with a First Unprovoked VTE: A Multicenter Prospective Cohort Study

Relationship Between Subtherapeutic Warfarin Anticoagulation and the Development of Post Thrombotic Syndrome After a First Unprovoked Deep Vein Thrombosis: Results From the REVERSE Cohort Study

Conservative Peri-Procedural Anticoagulation Management in Patients with Venous Thromboembolic Disease Results in a Low Proportion of Thrombosis and Bleeding

Study of Octaplex Dosing Accuracy: An In Vitro Analysis

A Canadian Expanded Access Trial of Oral Nilotinb in Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Prospective Canadian Trial In Newly Diagnosed Multiple Myeloma Patients with t(4;14): Bortezomib-Based Therapy without ASCT

A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial

Development of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only